查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1787226

全球神經認知評估與復健市場

Neurocognitive Assessment and Rehabilitation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 269 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球神經認知評估和復健市場規模將達到 217 億美元

全球神經認知評估與復健市場規模預計在2024年達到146億美元，預計在2024-2030年的分析期間內將以6.9%的複合年成長率成長，到2030年將達到217億美元。神經復健治療是本報告分析的細分領域之一，預計其複合年成長率將達到5.6%，到分析期結束時將達到125億美元。神經認知評估測試細分領域在分析期間的複合年成長率預計為8.9%。

美國市場規模估計為 40 億美元，中國市場預計複合年成長率為 10.5%

美國神經認知評估與復健市場規模預計在2024年達到40億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到45億美元，在2024-2030年的分析期間內，複合年成長率為10.5%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.5%和6.6%。在歐洲，預計德國市場的複合年成長率為4.5%。

全球神經認知評估和復健市場—主要趨勢和促進因素摘要

為什麼神經認知評估成為現代醫療保健的重要組成部分？

神經認知評估作為診斷、監測和管理不同年齡層和不同醫療條件下認知障礙的關鍵工具，正迅速獲得重要性。這些評估評估記憶力、注意力、執行功能、語言和處理速度等認知功能，幫助醫療保健提供者及早發現神經病變。隨著阿茲海默症、帕金森氏症、創傷性腦損傷 (TBI)、中風以及注意力不足過動症和自閉症等神經發育障礙的盛行率不斷上升，神經認知測試在臨床和研究環境中已變得至關重要。傳統的評估方法，包括紙本認知測試和結構化臨床訪談，正擴大得到提供客觀、數據驅動洞察的數位工具的補充。先進的神經影像技術，如功能性磁振造影 (fMRI)、正子斷層掃描 (PET) 和腦電圖 (EEG)，也被納入認知評估中，以更深入地了解大腦功能。此外，人工智慧 (AI) 和機器學習在神經認知測試中的應用可以識別傳統方法無法檢測到的細微認知變化，從而提高診斷的準確性。遠端醫療和行動醫療(行動醫療) 應用為無法親自前往醫療機構的患者提供遠距認知篩檢，進一步提高了醫療服務的可近性。隨著全球人口老化和神經退化性疾病負擔的持續加重，對高效、準確、可擴展的神經認知評估解決方案的需求預計將重塑認知醫療的未來。

神經認知復健面臨的主要挑戰是什麼？

儘管取得了顯著進展，神經認知復健仍面臨許多挑戰，影響其有效性和廣泛應用。一個主要問題是患者對復健介入措施反應的差異性，因為認知恢復具有高度的個體差異，取決於疾病的嚴重程度、潛在疾病以及對治療計劃的依從性等因素。此外，獲得專業復健服務仍然是一個主要問題，尤其是在神經系統護理基礎設施有限的中低收入國家。許多醫療保健系統缺乏訓練有素的神經心理學家、治療師和復健專家，導致認知障礙患者的治療延遲或治療效果不佳。另一個重大挑戰是缺乏標準化的神經認知復健通訊協定。不同醫療保健提供者的治療方法存在差異，這使得比較研究和臨床結果變得困難。此外，神經復健計畫（包括認知治療課程、輔助科技和家庭復健工具）的高昂費用可能對許多患者構成障礙。認知復健的保險覆蓋範圍因地區而異，某些保單不涵蓋或限制長期神經復健治療的保險報銷。此外，認知復健需要持續的努力，這對於記憶力受損、疲勞和注意力缺陷的患者來說，是一個挑戰。應對這些挑戰需要多管齊下的方法，包括增加對神經復健研究的投入、改善醫療服務的可近性，以及開發滿足不同患者需求的創新且經濟高效的解決方案。

科技進步將如何改變神經認知復健？

科技創新正在深刻改變神經認知復健的格局，這些創新提升了認知療法的有效性、效率和可及性。最具影響力的進展之一是將虛擬實境 (VR) 和擴增實境(AR) 融入認知復健計劃，使患者能夠參與模擬現實世界認知挑戰的身臨其境型互動訓練練習。這些技術能夠提高腦損傷或神經退化性疾病復健患者的記憶力、解決問題和決策能力，提供高度參與和個人化的復健體驗。腦機介面 (BCI) 和神經回饋系統的使用也具有突破性意義，它們透過即時監測和調節大腦活動來增強與認知功能相關的神經通路。此外，行動健康應用程式和人工智慧主導的認知訓練平台正在徹底改變居家康復，為患者和臨床醫生提供即時進度追蹤，同時提供遊戲化練習，鼓勵持續的認知參與。穿戴式生物感測器和智慧型裝置透過收集生理和認知數據，進一步增強神經認知康復，從而幫助制定個人化治療策略。巨量資料分析的興起也發揮著關鍵作用，它推動了預測模型的開發，用於評估復健進展並相應地制定干涉措施。隨著這些創新的不斷發展，神經認知復健將變得更加動態、以患者為中心，並能更好地適應個別需求，從而改善長期認知恢復的效果。

是什麼推動了神經認知評估和復健市場的成長？

神經認知評估和復健市場的成長受到多種因素的推動，包括神經系統疾病盛行率的上升、數位醫療技術的進步以及對個人化認知復健解決方案日益成長的需求。阿茲海默症和帕金森氏症等神經退化性疾病在全球的增多，加上人口老化，推動了對早期認知評估和長期復健策略的需求。此外，運動員、軍人和事故受害者對創傷性腦損傷 (TBI) 影響的認知不斷提高，這加速了對高階認知復健計畫的投資。遠端醫療和遠距醫療服務的擴展也在使神經認知評估工具更易於獲取方面發揮關鍵作用，使患者能夠在舒適的家中接受評估和治療。主導的診斷、數位認知訓練平台和穿戴式認知監測設備的日益普及，為臨床和家庭認知護理提供了創新解決方案，進一步推動了市場成長。製藥業也在促進市場擴張，其正在進行的神經保護和認知增強療法研究旨在補充復健工作。此外，監管機構對心理健康和認知護理計劃的支持正在推動資金和報銷政策的製定，鼓勵神經認知評估融入主流醫療保健。向數據主導醫療保健和個人化醫療的轉變也為精準神經復健創造了機會，精準神經復健可根據個人的認知狀況和進展指標量身定做治療方案。隨著這些因素持續影響神經認知評估和復健市場，預計該行業將持續成長，為改善全球個人的認知健康和生活品質提供創新解決方案。

部分

組成部分類型（神經復健治療、神經認知評估測試）；提供者類型（復健中心、醫院和診所、家庭護理機構、物理治療中心）

受訪公司範例

  • AnthroTronix Inc.
  • BioSensics
  • BrainCheck, Inc.
  • BrainScope Company, Inc.
  • Cambridge Cognition Holdings plc
  • CNS Vital Signs, LLC
  • Cogstate Ltd.
  • Constant Therapy Health
  • Encompass Health
  • Lumos Labs, Inc.（Lumosity）
  • MindMaze
  • NeuroCare Group
  • Neuroelectrics Corporation
  • NeuronUP SL
  • Neurotrack Technologies Inc.
  • Paradigm Healthcare
  • Posit Science Corporation
  • Qbtech AB
  • SCHUHFRIED GmbH
  • XRHealth

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP32323

Global Neurocognitive Assessment and Rehabilitation Market to Reach US$21.7 Billion by 2030

The global market for Neurocognitive Assessment and Rehabilitation estimated at US$14.6 Billion in the year 2024, is expected to reach US$21.7 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Neurorehabilitation Therapy, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$12.5 Billion by the end of the analysis period. Growth in the Neurocognitive Assessment Testing segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.0 Billion While China is Forecast to Grow at 10.5% CAGR

The Neurocognitive Assessment and Rehabilitation market in the U.S. is estimated at US$4.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.5 Billion by the year 2030 trailing a CAGR of 10.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Neurocognitive Assessment and Rehabilitation Market - Key Trends & Drivers Summarized

Why Is Neurocognitive Assessment Becoming a Crucial Component of Modern Healthcare?

Neurocognitive assessment is rapidly gaining importance as a critical tool for diagnosing, monitoring, and managing cognitive impairments across various age groups and medical conditions. These assessments evaluate cognitive functions such as memory, attention, executive function, language, and processing speed, helping healthcare providers identify neurological disorders at an early stage. With the rising prevalence of conditions like Alzheimer’s disease, Parkinson’s disease, traumatic brain injuries (TBI), stroke, and neurodevelopmental disorders such as ADHD and autism, neurocognitive testing has become indispensable in clinical and research settings. Traditional assessment methods, including paper-based cognitive tests and structured clinical interviews, are being increasingly supplemented by digital tools that offer objective and data-driven insights. Advanced neuroimaging techniques such as functional MRI (fMRI), positron emission tomography (PET), and electroencephalography (EEG) are also being integrated into cognitive assessments, providing a deeper understanding of brain function. Moreover, the adoption of artificial intelligence (AI) and machine learning in neurocognitive testing is enhancing diagnostic accuracy by identifying subtle cognitive changes that may be undetectable through conventional methods. Telemedicine and mobile health (mHealth) applications are further driving accessibility, allowing remote cognitive screening for patients who cannot visit healthcare facilities in person. As the global population ages and the burden of neurodegenerative diseases continues to grow, the demand for efficient, accurate, and scalable neurocognitive assessment solutions is expected to rise, reshaping the future of cognitive healthcare.

What Are the Key Challenges in Neurocognitive Rehabilitation?

Despite significant advancements, neurocognitive rehabilitation faces numerous challenges that impact its effectiveness and widespread adoption. One of the primary concerns is the variability in patient responses to rehabilitation interventions, as cognitive recovery is highly individualized and depends on factors such as the severity of impairment, underlying health conditions, and adherence to treatment plans. Additionally, access to specialized rehabilitation services remains a major issue, particularly in low- and middle-income countries where neurological care infrastructure is limited. Many healthcare systems struggle with a shortage of trained neuropsychologists, therapists, and rehabilitation specialists, leading to delayed or suboptimal treatment for individuals with cognitive impairments. Another critical challenge is the lack of standardized protocols for neurocognitive rehabilitation, as different healthcare providers may use varying therapeutic approaches, making it difficult to compare outcomes across studies and clinical settings. Furthermore, the high cost of neurorehabilitation programs, including cognitive therapy sessions, assistive technologies, and home-based rehabilitation tools, can be a barrier for many patients. Insurance coverage for cognitive rehabilitation varies across regions, with some policies excluding or limiting reimbursements for long-term neurorehabilitation therapies. Additionally, patient engagement and motivation remain significant hurdles, as cognitive rehabilitation requires sustained effort, which can be challenging for individuals experiencing memory deficits, fatigue, or reduced attention spans. Addressing these challenges requires a multi-faceted approach, including increased investment in neurorehabilitation research, improved accessibility to care, and the development of innovative, cost-effective solutions that cater to diverse patient needs.

How Are Technological Advancements Transforming Neurocognitive Rehabilitation?

The landscape of neurocognitive rehabilitation is undergoing a significant transformation, driven by technological innovations that enhance the effectiveness, efficiency, and accessibility of cognitive therapy. One of the most impactful advancements is the integration of virtual reality (VR) and augmented reality (AR) in cognitive rehabilitation programs, allowing patients to engage in immersive, interactive training exercises that simulate real-world cognitive challenges. These technologies provide a highly engaging and personalized rehabilitation experience, improving memory, problem-solving, and decision-making skills in patients recovering from brain injuries or neurodegenerative conditions. Another breakthrough is the use of brain-computer interfaces (BCIs) and neurofeedback systems, which enable real-time monitoring and modulation of brain activity, allowing individuals to strengthen neural pathways associated with cognitive function. Additionally, mobile health applications and AI-driven cognitive training platforms are revolutionizing home-based rehabilitation, offering gamified exercises that encourage continuous cognitive engagement while providing real-time progress tracking for both patients and clinicians. Wearable biosensors and smart devices are further enhancing neurocognitive rehabilitation by collecting physiological and cognitive data that help personalize treatment strategies. The rise of big data analytics is also playing a crucial role, enabling the development of predictive models that assess rehabilitation progress and adjust interventions accordingly. As these technological innovations continue to evolve, neurocognitive rehabilitation is becoming more dynamic, patient-centered, and adaptable to individual needs, leading to improved long-term cognitive recovery outcomes.

What Is Driving the Growth of the Neurocognitive Assessment and Rehabilitation Market?

The growth in the neurocognitive assessment and rehabilitation market is driven by several factors, including the increasing prevalence of neurological disorders, advancements in digital health technologies, and the rising demand for personalized cognitive rehabilitation solutions. The global rise in neurodegenerative diseases such as Alzheimer’s and Parkinson’s, coupled with an aging population, is fueling the demand for early cognitive assessments and long-term rehabilitation strategies. Additionally, the growing awareness of the impact of traumatic brain injuries (TBI) in athletes, military personnel, and accident victims has accelerated investments in advanced cognitive rehabilitation programs. The expansion of telemedicine and remote healthcare services has also played a pivotal role in making neurocognitive assessment tools more accessible, allowing patients to receive evaluations and therapy sessions from the comfort of their homes. The increasing adoption of AI-driven diagnostics, digital cognitive training platforms, and wearable cognitive monitoring devices is further enhancing market growth, providing innovative solutions for both clinical and at-home cognitive care. The pharmaceutical industry is also contributing to market expansion, with ongoing research into neuroprotective drugs and cognitive-enhancing therapeutics aimed at complementing rehabilitation efforts. Moreover, regulatory support for mental health and cognitive care initiatives is driving funding and reimbursement policies that promote the integration of neurocognitive assessment into mainstream healthcare. The shift toward data-driven healthcare and personalized medicine is also creating opportunities for precision neurorehabilitation, where treatment plans are tailored based on individual cognitive profiles and progress metrics. As these factors continue to shape the neurocognitive assessment and rehabilitation market, the industry is expected to witness sustained growth, offering transformative solutions that improve cognitive health and quality of life for individuals worldwide.

SCOPE OF STUDY:

The report analyzes the Neurocognitive Assessment and Rehabilitation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component Type (Neurorehabilitation Therapy, Neurocognitive Assessment Testing); Providers Type (Rehab Centers, Hospital & Clinics, Homecare Settings, Physiotherapy Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • AnthroTronix Inc.
  • BioSensics
  • BrainCheck, Inc.
  • BrainScope Company, Inc.
  • Cambridge Cognition Holdings plc
  • CNS Vital Signs, LLC
  • Cogstate Ltd.
  • Constant Therapy Health
  • Encompass Health
  • Lumos Labs, Inc. (Lumosity)
  • MindMaze
  • NeuroCare Group
  • Neuroelectrics Corporation
  • NeuronUP SL
  • Neurotrack Technologies Inc.
  • Paradigm Healthcare
  • Posit Science Corporation
  • Qbtech AB
  • SCHUHFRIED GmbH
  • XRHealth

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Neurocognitive Assessment and Rehabilitation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Neurological Disorders Propels Demand for Neurocognitive Assessment Tools
    • Aging Global Population Base Expands Addressable Market Opportunity for Cognitive Rehabilitation Solutions
    • Advancements in Brain-Computer Interface (BCI) Technology Strengthen Business Case for AI-Powered Neurotherapy
    • Integration of Digital Therapeutics and Gamification Drives Patient Engagement and Adoption Rates
    • Shift Toward Remote and Home-Based Healthcare Delivery Models Accelerates Demand for Portable Cognitive Assessment Devices
    • Growing Emphasis on Early Diagnosis of Dementia and Alzheimer's Drives Adoption of Screening Technologies
    • Increasing Use of Wearable Neuro-Monitoring Devices Spurs Growth in Real-Time Cognitive Tracking
    • Rising Investments in Neuroscience Research and Innovation Propels Development of Next-Gen Assessment Platforms
    • Favorable Reimbursement Policies in Developed Markets Sustain Growth Momentum for Cognitive Rehab Services
    • Regulatory Push for Standardization of Neurocognitive Testing Protocols Drives Market Formalization and Expansion
    • Convergence of Neuroimaging and Cognitive Analytics Expands Diagnostic and Rehabilitation Capabilities
    • Growing Application of AI and Machine Learning in Personalized Cognitive Rehabilitation Enhances Market Attractiveness
    • Emergence of VR and AR-Based Cognitive Therapy Solutions Generates High-Value Opportunities for Tech Innovators
    • Rising Adoption of Mental Health and Cognitive Wellness Programs in Corporate Settings Drives Market Penetration
    • Expanding Role of Cognitive Biomarkers in Clinical Trials Bolsters Demand for Digital Cognitive Assessment Tools
    • High Prevalence of Traumatic Brain Injuries Among Military and Sports Personnel Drives Demand for Targeted Rehabilitation Solutions
    • Integration of Cognitive Assessments in Primary Care Settings Broadens Market Reach and Accessibility
    • Public Awareness Campaigns on Cognitive Health and Aging Throw the Spotlight on Preventive Assessment Solutions
    • Rising Demand for Pediatric Cognitive Assessment Tools Driven by Growing Focus on Early Childhood Development
    • Cross-Industry Collaborations Between MedTech, Pharma, and Digital Health Players Accelerate Innovation Cycles
    • Data Privacy and Ethical Concerns Around Neurodata Collection Pose Regulatory Challenges and Impact Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurocognitive Assessment and Rehabilitation Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurorehabilitation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurorehabilitation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Neurorehabilitation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Neurocognitive Assessment Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Neurocognitive Assessment Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Neurocognitive Assessment Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Rehab Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Rehab Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Rehab Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospital & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospital & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospital & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Homecare Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Homecare Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Homecare Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Physiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Physiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Physiotherapy Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030

IV. COMPETITION